secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMGC Holdings Inc. (ELAB)
CIK:        0001840563
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001213900-25-044824
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMGC subsidiary Northstrive signs binding term sheet with Modulant for exclusive animal health license of EL-22
--------------------------------------------------------------------------------

- Northstrive grants Modulant exclusive global rights (ex-Korea) to develop/commercialize EL-22 as a probiotic for livestock muscle preservation.
- EL-22 targets the myostatin pathway via modified lactobacillus casei; Modulant is led by former Elanco executive Tom Campi.
- Modulant will pay Northstrive a share of all sublicensing and commercial revenues, with a royalty rate that decreases after a dollar limit.
- Definitive license agreement expected in coming months, subject to approval from Northstrive's head licensor for certain IP rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025044824/0001213900-25-044824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025044824/ea0241550-8k_pmgc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-044824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer